CBNGO00042—Innovative molecular platform for glycosylation research and therapeutic development 2190506-69-3

Glycan Oxazoline, as a key derivative in glycochemistry and glycobiology, is gradually becoming a core tool in cutting-edge biomedical research. This type of compound plays an irreplaceable role in the synthesis, modification and functional analysis of sugar chains through its unique oxygen-nitrogen heterocyclic structure, providing a new molecular basis for sugar engineering, vaccine design and disease treatment. As a representative molecule in this category, CBNGO00042 helps scientists deeply explore the mysteries of the world of glycosylation with its precise chemical structure and functional properties.

Chemical Information

Chemical name: CBNGO00042

Common name: Glycan Oxazoline

Chemical formula: C34H63NO20

Molecular weight: 805.86 g/mol

CAS number:

2190506

-69-3

Structural features

The structural core of Glycan Oxazoline lies in its oxazoline unit, which is formed by a cyclization reaction between the reducing end of the sugar group and the amino-containing component. This design gives it a series of unique properties:

Stable ring structure: The oxygen-nitrogen heterocyclic structure contains a five-membered ring, in which oxygen atoms and nitrogen atoms jointly participate in the ring system, which enhances the rigidity of the overall molecule. This architecture not only improves chemical stability but also reduces the risk of degradation under storage or reaction conditions, making it suitable for complex synthetic environments.

Simulates natural glycosidic bond formation: Compared with traditional glycosyl donors, Glycan Oxazoline can accurately simulate the enzymatic formation process of glycosidic bonds in organisms. Its cyclic structure can be used as an "activated" intermediate in the reaction to efficiently transfer sugar chains through enzymatic catalysis (such as glycoside hydrolase or glycosyltransferase) to achieve site-specific glycosylation, thereby avoiding by-products caused by non-selective modifications.

Enhanced steric and electronic effects: The electron distribution of the oxygen-nitrogen heterocycle optimizes the interaction with the enzyme active site, improving binding affinity through hydrogen bonding and hydrophobic interactions. At the same time, its stereochemical configuration allows a high degree of matching with natural sugar substrates, ensuring high enantioselectivity in biocatalysis, which is crucial for the synthesis of complex oligosaccharides with biological activity.

Multifunctional modification potential: Multiple hydroxyl and cyclic structural sites in the molecule can serve as anchor points for chemical modifications to facilitate the introduction of fluorescent labels, biotin or other functional groups, thereby expanding its use in probe development and diagnostic applications.

Main applications and advantages

1. Key tools for glycoprotein and glycolipid synthesis

In the field of glycoengineering, Glycan Oxazoline, as a highly efficient glycosylation donor, is promoting the preparation of homogeneous glycoconjugates. Traditional chemical glycosylation often faces problems such as low yield and difficult stereo control, but this compound can achieve mild and highly selective sugar chain transfer through enzymatic pathways. For example, in glycoprotein synthesis, it can be combined with engineered glycosidases to quickly construct core fucose or sialic acid modifications to generate glycoproteins with well-defined structures for functional studies. In addition, in glycolipid synthesis, its stability helps reduce hydrolysis side reactions, improve overall synthesis efficiency, and provide standard materials for membrane biology and immunology research.

2. Innovation platform for vaccine and therapeutic agent development

Glycan Oxazoline plays a central role in pathogen recognition and immune response, and Glycan Oxazoline provides new ideas for such applications. In vaccine design, this compound can be used to synthesize oligosaccharide chains that mimic bacterial or viral surface sugar antigens. These sugar chains can serve as immunogens to induce specific antibody responses, thereby developing sugar-conjugated vaccines against infectious diseases such as pneumococci or influenza. At the same time, in cancer immunotherapy, the synthesis of tumor-associated carbohydrate antigens relies on such intermediates to prepare personalized vaccines. In addition, certain Glycan Oxazoline derivatives can act as glycosidase inhibitors, interfering with pathogen glucose metabolism or cell adhesion, exhibiting anti-infectious or anti-metastatic potential.

3. Promotion of basic research and diagnostic technology

As a research tool, Glycan Oxazoline deepens the understanding of glycosylation mechanisms. In glycobiology, it is used to explore the role of glycans in cell signaling, protein folding, and host-pathogen interactions, such as tracking the dynamic process of glycosylation through enzymatic labeling. In diagnostics, modified versions could serve as probes to detect changes in the expression levels of specific sugar chains associated with cancer, neurodegenerative diseases or inflammatory states, supporting early biomarker discovery. In addition, in enzymology research, this type of compounds helps to analyze the structure-function relationship of sugar-processing enzymes and promote rational drug design.

Conclusion

Glycan Oxazoline represents a molecular bridge merging chemistry and biology, with value far beyond that of a simple reagent. From the basic science of deciphering the sugar code to developing next-generation glycosylation therapies, compounds like CBNGO00042 are unlocking the potential of glycoscience in precision medicine. With the advancement of glycoengineering technology, this type of molecules is expected to play a broader role in the prevention and control of infectious diseases, cancer treatment and metabolic disease intervention, leading a wave of sugar-oriented innovation.

The above information is provided by the editor of KASONS and is for scientific research only.